Epilepsy is a neurological disorder that is characterized by recurrent seizures. Cannabidiol (CBD) is a non-psychoactive compound found in the cannabis plant that has shown promise in reducing seizure frequency and severity in some individuals with epilepsy. In 2018, the United States Food and Drug Administration (FDA) approved the first CBD-based medication, Epidiolex, for the […]